# AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment

> **Open Intelligence Dossier** · First detected: 2026-10-05 23:20 UTC · Category: Business

## Executive Summary
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment" is generating significant coverage in the Business category, with 8 articles from 7 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo Finance, AstraZeneca, Reuters and finchannel. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway Combos | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxNdWw5NEVpcE1ZdEZCV0w4ZTJVQ3N6MFptMGlCdTdlcm9PT0NoNjFwXzR0VXNOUkMwNEZtekk5WWl5QVR4UjZXR196bUFfRk5oeDFJVE5xR09qNU5UREZxajU4RGdmVzl4bGdDbUhzNGhOV2FFV2IwekZqRnlwa3BMZTJyMnRRZ2lsTll3MGI0aVk?oc=5) |
| AstraZeneca | AstraZeneca completes equity investment in Summit Therapeutics | [Source Link](https://news.google.com/rss/articles/CBMixwFBVV95cUxPYjVkTnJqVFpZdDlSMFNmdGVJNlNtR0lyd1F4YXJ4SjFoRU1yOFZuQzJ5Q0VwZlBEUUFmSTBoTEpFQzMzZUlJR1JHa3VpQnJlaDRRU1p3Z1FLSlJfSUl4djUxQ1ljc2J1dWJHSG1pc052QXdxaWJXVzJqWnJOQUs2VkFzTFVYX01ZY0hLa1NST19oRWpfem9yYWY0dG1jMHBVTmZON2JZcVgtd1RFOWJKNHliQ0xRbkN4QVQ5dFk4ZDFQT3R3eUlJ?oc=5) |
| Reuters | AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination | [Source Link](https://news.google.com/rss/articles/CBMixwFBVV95cUxNMVNoZTkwVjRoUjd3eHBBRmNaenRuM1RmODZBd2dYd0ZPZ0Q4Nmtmc2xTc2VpZ2M0dE93UHFrc0h1dzZqREtOcHFlRUZrNXJmTl83ME0xdVNhLWhkdTRDeGZvWm1ZZTFGWUxhSHNsX19qc09US25qSmZKZUYtOWtZZHR6YmMta3VaYm01b0dOczBFMEc5X2xSUkJJbUFhQVhRQ2g0c0VCUTZEYVMxRWV6VzBBS0ZULUpESnlpVk0wa1RyZ1lZSmxv?oc=5) |
| finchannel | AstraZeneca Completes $2 Billion Investment in Summit Therapeutics | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxNT3VNVlVwa19VQTFWMXQ1czR0Q3Ziekx4TnNtN1RHdXMzZHdBTG41MGRtX083MW91VGtsVjlOUFA2cUtPdVdQMjZlby05eXktNHU5ZG9PQmJPZERCR3ZjNmNrME9KUTBHZW1RZHJXQ08yVXlfZHVlb1dtQm02NFlJanBUOTJuZmNBbm5sX0xtUkcyTTdxQk5ZNFg3bkRMeWNxYy1RdFR4TW8wSDB2QTVOWkUwcHVSMjJaQVV0NkR4UEl0QllEc2kycA?oc=5) |
| Endpoints News | Summit partners with AstraZeneca and Daiichi; Eccogene earns $50M milestone | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxQOUp3R0o1UGplekdzNzVXT21DLVNrUHdXWXFYQUZGNHlpdndnQS00QnN2NXpWRlVBRFRGbHJjbzlyRXYzeTdDbXRRdm45a24wTzBpTl92eEtuQlJFdGhFOEVJcFh0NFozTjRpME5qektabXJGb2NMMmE3dnBjU2lVcnlxNndsVHNFTGxIaEpIblFpaGtjbmR1UWEteVNXdw?oc=5) |
| Fierce Pharma | Fierce Pharma Asia—AZ’s $2B bet on ivonescimab; Novo buys Hengrui GLP-1; Merck doubles down on KRAS | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxNSmFKVkYzdUsxVmFZYzA2Vm9CdmRDNTUyYWRneW56OVZUMWEtdEFLTkxpZDZnc1ZUM1lNbF9QQTJhdndWU3ZpZEZMVU9fUWJHNTVJTUVuMTVHSTFMWVJlakQ2RjJVWEhWVXBkeEtsRmtPMmNjS053cm1kemFrcmstZ1JSdXRkNXYtUlJRblBsVnR4VVkzWjN6OFJGUHBBVTNhLVRhVDJyLXY0Q3dsTzhOTDhoTWs?oc=5) |
| AstraZeneca | AstraZeneca and Daiichi Sankyo announce clinical collaboration with Summit Therapeutics to evaluate Datroway in combination with ivonescimab across multiple tumour types | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxQb0phdWk3M1hhXzFIaU92cmgwTV9tc0lDUkg4QlBCa0xUR0F3aFA2czdSc056LWVHeWduVWpXSDF6c1c5UFlLNWl2bnRWb3kyMU5jOG5zTm01cndMNHdnU0ZRbFFWZ1lxU1VFdEQ5ZTBEUXJleGxyRDJNTXZiSTBTeXljeE56Y0pPbUx1X1BiR2hWaGhTWkpma3J1RHVDTTdpNjE1QTVZa2piUnEwR1FJ?oc=5) |
| CNBC | AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxNbERpRUxYR2Vkb3cwSXlwT0s4YlhpNkVRNUIxc3lRZWpyUThOejNvd090YXpLS0NBdkZwbmlhT19IRWMtYlpGUjROT1pIYS1GZ2o3UDcxMWo3SkZTWm1vbEc2WWNodi1tNjNXSzd1RWVGVW9jVkIyT1lBdGxrRzFMN2JJVDEycjFMSTYzbnkyVGRRaFZjazItdEU5RnpiU2VpbWV0N9IBqgFBVV95cUxNelpIX1ZIb0liODNQVjhlbHkwR0xfRFFQV1NHbk9ST2ZnaG1VaGVXcFJMZmIzTE1falFKUy03eHppSElrV1ZrZU5xY3VISzhncnBVWDEwLTUyLVhrVWJzeHhGSVBGSzRLa2FRekpHUVJsYV9RZmJHWFlWOXN2b3BUZy1hZGFueUdJVjJvMnVHa1hLQzlDeVVRc1o3dWhZdHh6SWphWWdDQmVyQQ?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-05/astrazeneca-ceo-says-summit-drug-could-drive-next-generation-of-cancer*